Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Pharma industry:...

    Pharma industry: Generic drug exports to Japan may be profitable

    Written by supriya kashyap kashyap Published On 2016-11-22T11:27:00+05:30  |  Updated On 22 Nov 2016 11:27 AM IST
    Pharma industry: Generic drug exports to Japan may be profitable

    Mumbai : Indian pharma industry sees a big potential for exporting generic drugs to Japanese market, a senior industry official said.


    "Japan is leading global market for patented and branded pharma products. But due to ageing population and budget constraints, it is encouraging generic drugs. We see good opportunity for exporting generics in the Japanese market," Pharmexcil Director General Dr. Appaji told on the sidelines of the pharma event 'CPhI & P-MEC 2016'.


    Pharmaceutical Export Promotion Council of India (Pharmexcil) is the authorised agency of the government for promotion of pharmaceutical exports from India.


    Appaji said the country exports its one-third pharma products to US alone. "But we are looking at more opportunities in Japan and Latin American markets," he said.


    He pointed out that in the US dollar terms, the pharmaceutical exports from India fell by over one per cent in the six months to September this fiscal as pricing pressures and a host of other factors took a big toll on the overseas shipments.


    "However, the domestic market grew 12 per cent in the first six months of current fiscal," Appaji said.


    The 10th edition of CPhI India and P-MEC, one of the world's leading pharma networking expos of UBM India, kicked off.


    A total of 1,300 exhibitors and 40,000 attendees from more than 100 countries are taking part in the event.


    According to a research, India is among the fastest-growing pharmaceutical markets in world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce give the industry a definite competitive advantage.


    Indian pharma industry accounts for about 2.4 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms. It is expected to expand at USD 55 billion by 2020.


    As per industry experts, generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally. This number is expected to grow even further in the coming years.

    Dr Appajigeneric drugindian pharma industryPharmaceutical Export Promotion Council of IndiaPharmexcil
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok